John-Arne Røttingen, director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health which conducted clinical trials of the vaccine in Guinea, talks to VOA about the promising new Ebola vaccine.
VOA Interview: John-Arne Rottingen Dir of Infectious Disease Control at Norwegian Institute of Public Health